MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects; D002143:Callitrichinae; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D008297:Male; D009048:Motor Skills / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000378:metabolism; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000188:drug therapy; D011725:Pyridines / Q000633:toxicity*
D000978:Antiparkinson Agents; D018377:Neurotransmitter Agents; D011725:Pyridines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine